Accordingly, the concurrent high expression of FoxM1 and PLK1 showed a high correlation with survival of primary and advanced NSCLC patients, particularly in LUAD but not in LUSQ. The gene discussed is FOXM1; the disease is non-small cell lung carcinoma.